Varicella mortality: trends before vaccine licensure in the United States, 1970-1994
- PMID: 10915066
- DOI: 10.1086/315714
Varicella mortality: trends before vaccine licensure in the United States, 1970-1994
Abstract
We examined varicella deaths in the United States during the 25 years before vaccine licensure and identified 2262 people who died with varicella as the underlying cause of death. From 1970 to 1994, varicella mortality declined, followed by an increase. Mortality rates were highest among children; however, adult varicella deaths more than doubled in number, proportion, and rate per million population. Despite declining fatality rates, in 1990-1994, adults had a risk 25 times greater and infants had a risk 4 times greater of dying from varicella than did children 1-4 years old, and most people who died of varicella were previously healthy. Varicella deaths are now preventable by vaccine. Investigation and reporting of all varicella deaths in the United States is needed to accurately document deaths due to varicella, to improve prevention efforts, and to evaluate the vaccine's impact on mortality.
Similar articles
-
Decline in mortality due to varicella after implementation of varicella vaccination in the United States.N Engl J Med. 2005 Feb 3;352(5):450-8. doi: 10.1056/NEJMoa042271. N Engl J Med. 2005. PMID: 15689583
-
Near elimination of varicella deaths in the US after implementation of the vaccination program.Pediatrics. 2011 Aug;128(2):214-20. doi: 10.1542/peds.2010-3385. Epub 2011 Jul 25. Pediatrics. 2011. PMID: 21788222
-
One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?Pediatrics. 2006 Jun;117(6):e1070-7. doi: 10.1542/peds.2005-2085. Pediatrics. 2006. PMID: 16740809
-
Varicella vaccination of children in the United States: assessment after the first decade 1995-2005.J Clin Virol. 2005 Jun;33(2):89-95; discussion 96-8. doi: 10.1016/j.jcv.2005.02.003. J Clin Virol. 2005. PMID: 15911422 Review.
-
Successes and remaining challenges after 10 years of varicella vaccination in the USA.Expert Rev Vaccines. 2006 Apr;5(2):295-302. doi: 10.1586/14760584.5.2.295. Expert Rev Vaccines. 2006. PMID: 16608428 Review.
Cited by
-
Intravenous immunoglobulin in children with streptococcal toxic shock syndrome.Clin Infect Dis. 2009 Nov 1;49(9):1369-76. doi: 10.1086/606048. Clin Infect Dis. 2009. PMID: 19788359 Free PMC article.
-
Varicella vaccine safety and immunogenicity in patients with juvenile rheumatic diseases receiving methotrexate and corticosteroids.Arthritis Care Res (Hoboken). 2010 Jul;62(7):903-6. doi: 10.1002/acr.20234. Arthritis Care Res (Hoboken). 2010. PMID: 20506363 Free PMC article. No abstract available.
-
25 Years of Varicella Vaccination in the United States.J Infect Dis. 2022 Oct 21;226(Suppl 4):S375-S379. doi: 10.1093/infdis/jiac251. J Infect Dis. 2022. PMID: 36265845 Free PMC article. No abstract available.
-
Warp Speed for Coronavirus Disease 2019 (COVID-19) Vaccines: Why Are Children Stuck in Neutral?Clin Infect Dis. 2021 Jul 15;73(2):336-340. doi: 10.1093/cid/ciaa1425. Clin Infect Dis. 2021. PMID: 32945335 Free PMC article.
-
Safety, immunogenicity and immediate pain of intramuscular versus subcutaneous administration of a measles-mumps-rubella-varicella vaccine to children aged 11-21 months.Eur J Pediatr. 2010 Aug;169(8):925-33. doi: 10.1007/s00431-010-1142-6. Epub 2010 Feb 11. Eur J Pediatr. 2010. PMID: 20148263 Clinical Trial.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical